6.10
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$6.11
Aprire:
$6.22
Volume 24 ore:
3.74M
Relative Volume:
0.75
Capitalizzazione di mercato:
$1.59B
Reddito:
$6.22B
Utile/perdita netta:
$187.00M
Rapporto P/E:
8.5124
EPS:
0.7166
Flusso di cassa netto:
$508.00M
1 W Prestazione:
-2.09%
1M Prestazione:
-18.77%
6M Prestazione:
-39.72%
1 anno Prestazione:
-58.56%
Organon Co Stock (OGN) Company Profile
Nome
Organon Co
Settore
Industria
Telefono
551-430-6000
Indirizzo
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OGN
Organon Co
|
6.10 | 1.59B | 6.22B | 187.00M | 508.00M | 0.7166 |
|
LLY
Lilly Eli Co
|
916.31 | 806.39B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
239.93 | 566.67B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
207.18 | 362.83B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
MRK
Merck Co Inc
|
119.37 | 287.71B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
AZN
Astrazeneca Plc
|
187.14 | 288.11B | 58.80B | 10.24B | 8.98B | 3.2788 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-10-27 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Downgrade | Goldman | Buy → Neutral |
| 2023-09-21 | Iniziato | Barclays | Overweight |
| 2023-03-16 | Iniziato | Raymond James | Outperform |
| 2022-10-14 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Iniziato | Piper Sandler | Neutral |
| 2021-09-01 | Iniziato | BofA Securities | Buy |
| 2021-07-22 | Iniziato | Citigroup | Buy |
| 2021-06-15 | Iniziato | JP Morgan | Neutral |
| 2021-06-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Organon Co Borsa (OGN) Ultime notizie
Organon & Co stock faces renewed scrutiny amid women's health sector shifts and pipeline updates - AD HOC NEWS
Organon sees opportunities in China's push for high-quality population development - China Daily
Organon & Co. Stock Plummets to New 52-Week Low of $5.76 - Markets Mojo
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Organon: A High Cash Yield Hidden Behind Patent Fatigue - TradingView
Organon & Co. (NYSE:OGN) Hits New 52-Week LowHere's Why - MarketBeat
Organon & Co. Hits New 52-Week Low at USD 6.16 Amidst Declining Performance - Markets Mojo
Assessing Organon (OGN) Valuation After Prolonged Share Price Weakness And A 33% Undervaluation Estimate - simplywall.st
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? - The Motley Fool
Does a $25 Million Investment in a Stock That Has Fallen 61% Indicate a Possible Recovery at $6? - Bitget
Sio Capital's New Organon Investment: A Value Play in Women's HealthNews and Statistics - IndexBox
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? - The Motley Fool
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility - MSN
Behavioral Patterns of OGN and Institutional Flows - Stock Traders Daily
Organon & Co stock hits 52-week low at 6.17 USD By Investing.com - Investing.com South Africa
Organon & Co stock hits 52-week low at 6.17 USD - Investing.com Australia
Organon (OGN) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility (IJR:NYSEARCA) - Seeking Alpha
Organon & Co. (NYSE:OGN) Hits New 12-Month LowHere's Why - MarketBeat
Organon rises after update on independent review - MSN
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates - GuruFocus
Investors heavily search Organon & Co. (OGN): Here is what you need to know - MSN
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Aug Wrap: Can Organon Co expand into new marketsWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Organon & Co. Experiences Evaluation Revision Amidst Market Challenges and Performance Divergence - Markets Mojo
Gotham Asset Management LLC Buys 1,007,691 Shares of Organon & Co. $OGN - MarketBeat
Organon (OGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Organon & Co. (OGN) Dividend Yield 2026, Date & History $OGN - MarketBeat
OGN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com Nigeria
Organon trades in red for seven straight sessions - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Organon & Co. (OGN) And Encourages Shareholders to Reach Out - ACCESS Newswire
(OGN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - Sahm
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
Royce & Associates LP Trims Position in Organon & Co. $OGN - MarketBeat
Organon climbs 6% after audit clears company of wrongdoing - MSN
Organon & Co. (OGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Organon & Co. Hits Day Low of $7.50 Amid Price Pressure - Markets Mojo
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Organon (OGN) HR chief gets stock awards, withholds shares for taxes - Stock Titan
Organon & Co. (NYSE:OGN) Short Interest Up 21.9% in February - MarketBeat
Organon (OGN) CFO granted shares, withholds stock to pay taxes - Stock Titan
Organon (OGN) executive reports PSU share awards and tax withholding - Stock Titan
Organon (OGN) CIO logs stock awards and tax withholding share disposals - Stock Titan
Organon (OGN) GC Weaver gets stock awards, shares withheld for tax - Stock Titan
Organon (NYSE: OGN) interim CEO reports stock awards and tax share offsets - Stock Titan
Can VTAMA’s Pediatric Sleep Data Nudge Organon (OGN) Toward a Stronger Dermatology-Led Growth Identity? - simplywall.st
Organon & Co. (OGN) Stock Analysis: Key Insights On Its 25.17% Potential Upside - DirectorsTalk Interviews
KDventures AB Announces Organon Discontinues Development of Forendo's Drug Candidate for Polycystic Ovarian Syndrome - marketscreener.com
Organon Co Azioni (OGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):